Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-22

Clinical Trial Update: Choline Effects - Pre-symptomatic AD [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the effects of choline in people who are pre-symptomatic for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Choline (Choline)

Snippet

Sponsor: Paul E Schulz | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED